Solid Tumors Harboring Ntrk Fusion clinical trials

Explore recruiting solid tumors harboring ntrk fusion clinical trials.

Recruiting solid tumors harboring ntrk fusion studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Solid Tumors Harboring Ntrk Fusion trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(20290) A Phase 1/2 Study of the Oral TRK Inhibitor Larotrectinib in Pediatric Patients with Advanced Solid or Primary Central Nervous System Tumors

France, Netherlands, Czechia, Italy, Germany, Sweden +3 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

(20289) A Phase 2 Basket Study of the Oral TRK Inhibitor larotrectinib in Subjects with NTRK Fusion-Positive Tumors

Spain, Germany, Denmark, Sweden, France, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Solid Tumors Harboring Ntrk Fusion trials by city

Solid Tumors Harboring Ntrk Fusion in Toronto Solid Tumors Harboring Ntrk Fusion in Vancouver Solid Tumors Harboring Ntrk Fusion in Montreal Solid Tumors Harboring Ntrk Fusion in Calgary Solid Tumors Harboring Ntrk Fusion in Edmonton Solid Tumors Harboring Ntrk Fusion in Ottawa Solid Tumors Harboring Ntrk Fusion in Winnipeg Solid Tumors Harboring Ntrk Fusion in Quebec City Solid Tumors Harboring Ntrk Fusion in Hamilton Solid Tumors Harboring Ntrk Fusion in Kitchener Solid Tumors Harboring Ntrk Fusion in London Solid Tumors Harboring Ntrk Fusion in Halifax Solid Tumors Harboring Ntrk Fusion in New York Solid Tumors Harboring Ntrk Fusion in Los Angeles Solid Tumors Harboring Ntrk Fusion in Chicago Solid Tumors Harboring Ntrk Fusion in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease